Embecta (EMBC) Free Cash Flow Growth (1y) (2021 - 2026)
Embecta (EMBC) Free Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.79 Bn | 121.57 Bn | 1.96 Bn | 44.68% |
| 2 | Becton Dickinson | 45.00 Bn | 44.18 Bn | 2.15 Bn | 271.70% |
| 3 | Alcon | 33.16 Bn | 31.50 Bn | 1.53 Bn | - |
| 4 | Medline | 32.87 Bn | 30.63 Bn | 1.84 Bn | -45.89% |
| 5 | Resmed | 29.50 Bn | 27.84 Bn | 890.98 Mn | -6.70% |
| 6 | West Pharmaceutical Services | 23.14 Bn | 22.71 Bn | 329.20 Mn | -20.71% |
| 7 | Solventum | 14.10 Bn | 13.54 Bn | 1.10 Bn | -241.25% |
| 8 | Cooper Companies | 13.88 Bn | 13.74 Bn | 735.40 Mn | 432.60% |
| 9 | Align Technology | 12.15 Bn | 11.09 Bn | 736.59 Mn | 339.10% |
| 10 | Embecta | 206.06 Mn | 12.66 Mn | 127.80 Mn | -3.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.47% |
| Dec 31, 2025 | 344.12% |
| Sep 30, 2025 | 188.35% |
| Jun 30, 2025 | 784.75% |
| Mar 31, 2025 | 51.67% |
| Dec 31, 2024 | 56.96% |
| Sep 30, 2024 | 30.39% |
| Jun 30, 2024 | 26.71% |
| Mar 31, 2024 | 211.17% |
| Dec 31, 2023 | -128.37% |
| Sep 30, 2023 | -58.70% |
| Jun 30, 2023 | -158.55% |
| Mar 31, 2023 | -110.61% |
| Dec 31, 2022 | -58.59% |
| Sep 30, 2022 | -32.05% |
| Jun 30, 2022 | -77.51% |
| Mar 31, 2022 | 54.76% |
| Dec 31, 2021 | 22.27% |